In 2005, Mr. Bernard Richard, Ombudsman and Child and Youth Advocate for New Brunswick, contacted IMS to request a report on prescription patterns of stimulant drugs in New Brunswick. In particular, he expressed concerns about the safety and appropriateness of the use of these drugs such as methylphenidate or dextroamphetamine in school-aged children. IMS's findings are summarized in "Stimulant Use in New Brunswick", a poster presented at the 2007 CADTH (Canadian Agency for Drugs and Technologies in Health) Invitational Symposium held in April 2007.
The 2007 CADTH Symposium was a forum for producers and users of evidence-based information on drugs and other health technologies from all sectors – government, regional health authorities, health care professionals, agencies, academic centres, industry and consumers – to share information and learn from each other.
Canada’s federal, provincial and territorial health care decision makers rely on the Canadian Agency for Drugs and Technologies in Health to provide them with credible, impartial advice and evidence-based information about the effectiveness of drugs and other health technologies.
To access all the Symposium PowerPoint presentations and posters in PDF format in the language in which they were delivered, click here.